bioRxivCancer BiologyPreprint
CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer
J. M. Houthuijzen, R. de Bruijn, E. van der Burg, A. P. Drenth, E. Wientjens, T. Filipovic, E. Bullock, C. S. Brambillasca, M. Nieuwland, I. de Rink, F. van Diepen, S. Klarenbeek, R. Kerkhoven, V. Brunton, C. L. G. J. Scheele, M. C. Boelens, J. Jonkers
Abstract
Cancer-associated fibroblasts (CAFs) are abundantly present in the microenvironment of virtually all tumors and strongly impact tumor progression. Despite increasing insight into their function and heterogeneity, little is known regarding the origin of CAFs. Understanding the origin of CAF heterogeneity is needed to develop successful CAF-based targeted therapies. Through various transplantation studies in mice we determined that CAFs in both invasive lobular breast cancer and triple negative breast cancer originate from mammary tissue-resident normal fibroblasts (NFs). Single-cell transcriptomics, in vivo tracing and in vitro studies revealed the transition of CD26+ and CD26- NF populations into inflammatory CAFs (iCAFs) and myofibroblastic CAFs (myCAFs), respectively. In vitro functional assays showed that CD26+ NFs transition into pro-tumorigenic iCAFs which recruit myeloid cells in a CXCL12-dependent manner and enhance tumor cell invasion via matrix-metalloproteinase (MMP) activity. Together, our data show that CD26+ and CD26- NFs transform into distinct CAF subpopulations in breast cancer.
- organism: mouse
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: clustering
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single-cell transcriptome analysis reveals evolutionarily conserved features during the transition from normal breast stromal cells to cancer-associated fibroblasts
A. P. Delgado, A. Nemajerova, … S. Powers·bioRxiv·May 5, 2022
- Cancer-associated fibroblast compositions change with breast cancer progression linking S100A4 and PDPN ratios with clinical outcome
G. Friedman, O. Levi-Galibov, … R. Scherz-Shouval·Nature CancerPeer-reviewed·Jun 29, 2020
- Deciphering the temporal heterogeneity of cancer-associated fibroblast subpopulations in breast cancer
F. A. Venning, K. W. Zornhagen, … J. T. Erler·bioRxiv·May 5, 2020
- Myofibroblastic CAFs arising from bone-resident osteoblast precursors retain an osteolineage signature and support breast cancer progression via Osterix-mediated signaling.
Giulia Furesi, Carisa Zeng, … Roberta Faccio·bioRxiv·Sep 18, 2025
- Cancer cell-derived extracellular matrix promotes differentiation of fibroblasts into cancer-associated fibroblasts
Eyup Yondem, Devrim Pesen‐Okvur·bioRxiv·Apr 15, 2024
- Targeting of MCL-1 in breast cancer associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties
T. L. Bonneaud, L. Nocquet, … F. Souaze·bioRxiv·Sep 24, 2021